| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.3M | — | +11.0% |
| Cost of Revenue | $6.4M | — | +16.0% |
| Gross Profit | $1.9M | — | -3.2% |
| R&D Expense | $117K | — | +9.1% |
| SG&A Expense | $762K | — | +0.8% |
| Operating Income | -$86K | — | -24.3% |
| Pre-tax Income | -$237K | — | -54.0% |
| Net Income | -$241K | — | +13.1% |
| EPS (Basic) | -$0.02 | — | +0.0% |
| EPS (Diluted) | -$0.02 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $13.4M | +6.1% | +11.8% |
| Inventory | $12.5M | +18.8% | +12.5% |
| Current Assets | $34.2M | +4.0% | -5.1% |
| Total Assets | $63.9M | +3.4% | +3.6% |
| Current Liabilities | $13.4M | +24.3% | +0.6% |
| Long-term Debt | $4.3M | -2.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.8M | — | -234.0% |
| Capital Expenditures | $2.2M | — | +530.8% |
| Investing Cash Flow | -$1.5M | — | -323.7% |
| Financing Cash Flow | $2.6M | — | +52.6% |
| Free Cash Flow | -$4.1M | — | -351.0% |
| -46.7% |
| Total Liabilities | $21.3M | +12.1% | +7.0% |
| Stockholders' Equity | $38.8M | -0.2% | +1.0% |